Ouimette Mike 4
4 · PLIANT THERAPEUTICS, INC. · Filed Jan 25, 2023
Insider Transaction Report
Form 4
Ouimette Mike
General Counsel & Corp. Sec'y
Transactions
- Exercise/Conversion
Common Stock
2023-01-23$24.32/sh+10,000$243,200→ 25,947 total - Exercise/Conversion
Stock Option (right to buy)
2023-01-23−10,000→ 77,000 totalExercise: $11.86Exp: 2032-01-25→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2023-01-23$11.86/sh+10,000$118,600→ 15,947 total - Sale
Common Stock
2023-01-23$34.19/sh−20,000$683,878→ 5,947 total - Exercise/Conversion
Stock Option (right to buy)
2023-01-23−10,000→ 98,240 totalExercise: $24.32Exp: 2030-10-08→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022.
- [F2]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F3]25% of the shares subject to such option vested on October 1, 2021 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.